Coverage
-
July 13, 2026
Athletic apparel company Under Armour dodged claims that its marketing of bioceramic powder products as FDA-approved cost its former business partner money, with a Pennsylvania federal judge ruling Monday that there was no obvious link between the statements and the plaintiffs' losses.
12 other articles on this case.
View all »